Drug Type Small molecule drug |
Synonyms MR-301 |
Mechanism NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization SHINKEI Therapeutics LLCStartup |
Active Organization- |
Inactive Organization SHINKEI Therapeutics LLCStartup |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |